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Background: The economic burden of diseases has become increasingly relevant to policy makers as healthcare
expenditure keep rising in the face of limited and competing resources. Buruli ulcer (BU), a neglected but treatable
tropical disease caused by Mycobacterium ulcerans, the only known environmental mycobacterium is capable of
causing long term disability when left untreated. However, most BU studies have tended to focused on its
bacteriology, epidemiology, entomology and other social determinants to the neglect of its economic evaluation.
This paper reports estimated the household economic costs of BU and describe the intangible cost suffered by BU
patients in an endemic area.
Methods: Retrospective one year cost data was used. A total of 63 confirmed BU cases were randomly sampled for
the study. Economic cost and cost burden of BU were estimated. Sensitivity analysis was conducted to test the
robustness of the cost estimates. Intangible cost measured stigmatization, pain, functional limitation and social
isolation of children.
Results: The annual total household economic cost was US$35,915.98, of which about 65% was cost incurred by
children with a mean cost of US$521.04. The mean annual household cost was US$570.09. The direct cost was 96%
of the total cost. Non-medical cost accounts for about 97% of the direct cost with a mean cost of US$529.27. The
mean medical cost was US$18.94. The main cost drivers of the household costs were transportation (78%) and food
(12%). Caregivers and adult patients lost a total of 535 productive days seeking care, which gives an indirect cost
valued at US$1,378.67 with a mean of US$21.88. A total of 365 school days (about 1 year) were lost by 19 BU
patients (mean, 19.2 days). Functional loss and pain were low, and stigma rated moderate. Most children suffering
from BU (84%) were socially isolated.
Conclusion: Household cost burden of out-patient BU ulcer treatment was high. Household cost of BU is therefore
essential in the design of its intervention. BU afflicted children experience social isolation.
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Buruli ulcer (BU), is a neglected infectious disease of
tropical and subtropical climates caused by Mycobacterium
ulcerans, the only known environmental mycobacterium
and the third commonest mycobacterium after Mycobac-
terium tuberculosis and Leprosae. BU is capable of causing
long term disability when left untreated but though* Correspondence: mksaikins@ug.edu.gh
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distribution, and reproduction in any mediumthoroughly researched, has limited studies that evaluate its
economic burden [1-4]. The precise distribution and
prevalence of BU is unknown, but it is reported annually
in over 30 countries globally, the highest burden being in
Sub-Saharan Africa [4,5]. BU can affect people of all ages
but typically affects children less than 16 years and living
in swampy, rural impoverished communities with limited
access to healthcare [3,4,6,7]. Though the reservoir and
mode of transmission of Mycobacterium ulcerans remainsCentral Ltd. This is an open access article distributed under the terms of the
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in a BU endemic area is the most important risk factor for
acquiring BU [4,7-10]. Mycobacterium ulcerans secretes
mycolactone a powerful toxin that causes massive cutane-
ous tissue destruction and immunosuppression [4,9]. BU
presents as active disease of ulcerative or non-ulcerative
forms, or as inactive disease characterized by a deep star
shaped scar [4]. Recent use of rational antibiotic therapy
has improved clinical outcomes of BU limiting surgery to
large ulcers [7,11,12].
Ghana, the second BU most endemic country in the
world reports about 1,000 cases of BU annually [4,13].
Whilst knowledge about the aetiology of BU has im-
proved in affected Ghanaian communities, there is still
late reporting of the disease from fear of limb amputa-
tions, prolonged hospital stay, transportation and treat-
ment costs at health facilities, loss of earnings and
stigmatization of BU patients [1,14]. Poor implementa-
tion of free BU treatment services has led to inconsistent
service provision. However, free BU services excludes
transportation, feeding or accommodation costs of pa-
tients and their caregivers - a cost that has significant
implications to household economies [3,15,16]. There is
however, paucity of data on the cost and the burden of
BU on affected households in Ghana as well as intan-
gible costs borne by the patients. Though the indirect
cost of BU was estimated at $550 with 265 productive
days lost among ulcerative cases of BU in previous
Ghanaian studies, the total cost (direct and indirect) and
the economic burden of BU to household is unknown
[6,17]. The economic burden of diseases has become in-
creasingly important as healthcare expenditure rapidly
escalates whilst resources remain limited. This study was
conducted to estimate the household economic costs of
BU and describe the intangible cost suffered by BU pa-







Morbidity cost of B
Figure 1 Conceptual framework of household BU morbidity costs.Methods
Study area
The study was conducted in the Obom sub-district of the
Ga South Municipality, Greater Accra Region, Ghana in
May 2012. The first 5 districts nationwide with the
highest prevalence of BU are: Amasie West (150.8/
100,000), Asante Akim North (131.5/100,000), Upper
Denkyira (114.7/100,000), Afigya Sekyere (107.1/100,000)
and Ga (87.7/100,000) [1,2]. Thus the study district is
the fifth BU most endemic area in Ghana (i.e., prevalence
of 87.7/100,000) and it has the highest burden of BU re-
lated deformity and disability. Obom has 362 communities
with an estimated population of 210,727 and most adults
are engaged mainly in small scae agricultural activities.
The rural and swampy setting of Obom increases the
risk of acquiring BU. The Obom Health Centre (OHC),
the main centre for BU treatment has no BU ward and
therefore runs only an out-patient BU clinic. The OHC
also runs Community based Health Planning and Services
(CHPS) compounds that provide healthcare services
in the communities. A non-governmental organization
(NGO), “Stop Buruli Project” assists OHC by providing
transport fare, breakfast and some logistics to the OHC
and patients.
Study design
The study was a cross-sectional Cost-of-Illness study
(COIs) from the household perspective. Economic costs
were considered as shown in Figure 1. BU morbidity
costs associated with treatment service were classified
broadly into direct cost and disability costs [15]. The
direct costs were further categorized as i) Medical costs
included wound dressing supplies and other treatments
(i.e., medications and other laboratory tests). ii) Nonmedi-
cal cost included transportation costs and feeding costs
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[16]. The disability costs consisted of indirect costs and in-
tangible costs. The indirect costs were productivity loss
and school days lost by household members due to BU.
Productivity losses were valued using the human capital
approach [18-21] based on the actual local daily wage of
working adults. Productivity losses of unemployed adults
and children were not valued. Casual work was assumed
for all working adults. Finally cost burden incurred by
households were estimated. The local cost in Ghanaian
currency (i.e., Ghana Cedis) was converted to their US
dollar equivalents using the average exchange rate during
the study period. Intangible costs were measured by de-
scribing the stigma, pain functional limitation and social
isolation experienced by BU sufferers [14,15,22-24].
The number of school absenteeism days due to BU
was operationally measured as non-attendance of a full
school day session, and calculated as the summation of
the number of school days lost by BU patients and their
care givers of school going age, but was not valued in
monetary terms as children below the age of 18 years in
Ghana by law, are not employable.
Study population and sample size
Households with confirmed cases of BU at the OHC
from 18th May 2011 to 17th May 2012 constituted the
sample frame. An initial 105 confirmed cases was obtained
from OHC database. However, 3 cases were confirmed
dead and 3 others were conveniently sampled for pre-
testing the questionnaire bringing the final sampling frame
to 99 confirmed cases. Using BU prevalence in the area as
87.7/100,000 in 2002 [2] and a precision of 0.8% at 95%
confidence interval, the sample size was calculated using
the Cochran’s formula [25]:
n = (t2* p(1-p))/d2, where n is sample size, t is 1.96,
p is 0.000877 and d is 0.8% - a sample size of 52.6 was
obtained. The sample was further increase by a 20%
non-response rate and/or recording errors, and rounded
up to 63. Thus, a total of 63 confirmed BU cases and
their households were randomly sampled for the study.
Data collection
Respondents were followed into their communities and a
structured questionnaire was used to collect data on the
patients’ socio-demographic characteristics, household in-
come, direct, indirect and intangible costs associated with
seeking BU treatment services the last 12 months. Tele-
phone interviews were used to clarify responses after ini-
tial data collection. The most reported intangible cost of
BU are stigmatization, pain, functional limitation and so-
cial isolation [14,15,22-24]. Responses to queries on func-
tional limitation and stigma were collected on a 5 point
Likert scale [26]. Self reported felt stigma was studied
using Vlassoff queries and modified for respondents whowere children [24]. Data on functional limitation was
collected using the Buruli Ulcer Functional Limitation
Score Questionnaire (BUFLSQ). Functional limitation
was defined as impairment in carrying out daily activities
as a result of BU [22,23]. Daily activities listed in the
BUFLSQ irrelevant to a BU patient (either because the
patient is too young or old to perform the task), was re-
corded as not applicable. Self-reported ability to per-
form activities listed on the BUFLSQ was recorded
without respondents being required to perform the
tasks [22,23]. Self-reported perceived BU related pain
was measured using a modified short MacGill pain
questionnaire for children older than 11 years [27]. So-
cial isolation was measured as the frequency a child is
accompanied to the OHC by a caregiver during treatment
and operationally defined as a child not being accompan-
ied by a caregiver 50% of the time to the BU facility when
seeking care as by culture, in Ghana, children are accom-
panied by caregivers when seeking medical care.
Statistical and data analysis
Data was entered in Microsoft Excel 2007 and STATA
Version 10.0 was used for most of the analysis. The unit of
analysis was BU affected households. The total household
economic cost (i.e., medical, non-medical and indirect
costs), productive days lost, mean costs and confidence in-
tervals were estimated. Tables 1 and 2 provide details of
the cost and productive lost estimations and valuation.
The economic cost burden was estimated as a percentage
of the household cost of UB treatment divided by the total
household income. Sensitivity analysis was conducted to
determine the robustness of cost estimation.
The main intangible costs measured were stigmatization,
pain, functional limitation and social isolation. An overall
mean for stigma, pain and functional limitation was com-
puted as the mean of the means of each Likert scale item
for children and adults separately. The Mann–Whitney
test was used to compare Likert scale responses among
male and female. A p-value < 0.05 was considered sig-
nificant for Mann–Whitney tests. Social isolation was
calculated as the proportion of children who were not
accompanied to the OHC during treatment.
The main assumptions made were: i) Costs estimated
were incurred during the period, and were a consequence
of BU; ii) Household income prior to the onset of BU
would have remained constant over the 12 months
study period had BU not afflicted a household member;
and iii) Children did not work and so did not incur
productivity loss.
Ethical review
Ethical clearance for the study was obtained from the
Ethical Review Committee, Research and Development
Division of the Ghana Health Service, Ghana. Study
Table 1 Household direct costs of treating BU, Ghana, 2012
Direct costs Type of cost Cost (US$ per year)
Medical Wound dressing supplies Summation of the cost of all wound dressing supplies used during treatment
per month and normalized by sample size.
Other treatments Summation of all out-of-pocket payments incurred on drugs and laboratory
tests by BU patients at OHC per month and normalized by sample size.
Medical cost Summation of total costs of wound dressing supplies and other treatments.
Non-medical Transportation Summation of the number of visits made by the BU patient and/or with caregiver
to OHC per week multiplied by the return fare and normalized by sample size.
Food Summation of the cost of food bought for the patient and/or caregivers during BU treatment
at OHC per week multiplied by the number of BU patients and normalized by sample size.
Miscellaneous Summation of costs of phone calls made, cost of extra soap and disinfectants used for washing
of soiled clothing during BU treatment by all patients and normalized by sample size.
Nonmedical cost Summation of the total costs of transportation, food and miscellaneous.
Total direct cost Summation of total medical and non-medical costs.
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Health Administration and the Obom Health Centre man-
agement. Identified respondent/caregiver was informed
about the study. Respondent/caregiver was at liberty to
withdraw from the study at will. Respondent/caregiver
was assured of all information collected. Consented par-
ticipant/caregiver was interviewed alone and in privacy.
No compensations were paid to them. Written informed
consent was obtained from all respondents.
Results
Socio-demographic characteristics of the study
population
Table 3 shows that 52% of the BU cases were male and
about 62% of BU cases were less than 15 years old withTable 2 Household indirect costs of treating BU, Ghana, 2012
Indirect costs Time Estimation approa
Travel time Patient Summation of the p
by doubled travel t
Caregiver Summation of the p
by doubled travel t
Total travel time Summation of patie
Wound dressing time Patient Summation of the p
by the number of w
dressing and norma
Caregiver Summation of the p
the number of wou
of weeks of wound
Total wound dressing time Summation of patie
Valuation Type of cost Cost (US$ per yea
Productivity lost by patient Summation of the p
health care (i.e., trave
Productivity lost by caregiver Summation of the p
care (i.e., travel and w
Total indirect cost
(i.e., productivity lost)
This is the summatia median age of 13 years. Eighty-four percent of them
reported being Christians. About 74% had primary
school education of which 43% were male. Majority of
respondents (75%) were students/apprentices and 77%
lived in household size of 5 or more persons. Majority of
respondents (87%) had one lesion on their body with no
difference between the sexes. All households studied had
one household member suffering from BU except one
household that had 2 BU sufferers. The mean and median
duration of treatment was 3 months each.
Total and mean household economic costs
The annual total household economic cost was US
$35,915.98, of which about 65% was cost incurred by
children with a mean cost of US$521.04. The meanch
roduct of the number of visits by BU patients to OHC per week
ime (i.e., to and fro OHC) and normalized by sample size.
roduct of the number of visits by caregivers to OHC per week
ime (i.e., to and fro OHC) and normalized by sample size.
nt and caregiver travel times.
roduct of time spent on wound dressing (i.e., waiting and dressing)
ound dressing times per week by the number of weeks of wound
lized by sample size.
roduct of the caregiver’s waiting time spent on wound dressing by
nd dressing times accompanied by caregiver per week by the number
dressing accompanied by caregiver and normalized by sample size.
nt and caregiver travel times.
r)
roduct of the total number of workdays lost by adult BU patients in seeking
l and wound dressing times) by the average local daily wage rated.
roduct of the total number of workdays lost by caregivers in seeking health
ound dressing times) by the average local daily wage rated.
on of valued productive days lost by patient and caregiver.
Table 3 Socio-demographic characteristics of BU cases
Background characteristic Male (%) Female (%) Total (%)
Age (years)
<15 23 (37) 16 (25) 39 (62)
15 and over 10 (16) 14 (22) 24 (38)
Religion
Christian 27 (43) 26 (41) 53 (84)
Other† 6 (2) 4 (7) 10 (17)
Educational background
No education 1 (2) 5 (8) 6 (10)
Primary 27 (43) 20 (32) 47 (74)
Middle/JHS/JSS* 5 (8) 5 (8) 10 (16)
Occupation
Student/apprentice 27 (43) 20 (32) 47 (75)
Other 6 (10) 10 (16) 16 (15)
Household Size
<5 4 (6) 10 (16) 14 (22)
5 and over 29 (46) 20 (31) 49 (77)
Number of Buruli Ulcer lesions
1 28 (44) 27 (43) 55 (87)
2 and over 5 (8) 3 (5) 8 (13)
Total 33 (52) 30 (48) 63 (100)
*JHS and JSS means Junior High School and Junior Secondary
School respectively.
†Other includes Muslim, Traditional and Other minor religions.
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was 96% of the total cost. Non-medical cost accounts for
about 97% of the direct cost with a mean cost of US
$529.27. The mean medical cost was US$18.94. The main




Wound dressing supplies (i.e., bandages, gauze, disinfectants, vaseline) 504.32




Food (i.e., patient & caregiver) 3,094.
Miscellaneous (i.e., soap, clothes, disinfectants, phone calls etc.) 594.69
Sub-total: 22,555
Total direct cost 23,114
Total valued indirect cost (i.e., productivity lost) 332.98
Total cost (direct + indirect costs) 23,446
*Caregivers associated cost not children.
†Figures in parenthesis are means.(78%) and food (12%), with a mean cost of US$444.71 and
US$69.76 respectively. For both children (p = 0.11) and
adults (p = 0.89) there was no significant difference in
household cost among the sexes. Table 4 provides the total
and mean household economic costs.
Caregivers and adult patients lost a total of 535 pro-
ductive days seeking care, which gives an indirect cost
valued at US$1,378.67 with a mean of US$21.88. A total
of 365 school days (about 1 year) were lost by 19 BU
patients (mean, 19.2 days). Though most children were
able to go to school after receiving treatment, about 33%
[15] of them reported late to school due to time spent
seeking care at the facility. No BU caregiver was schooling.
The household economic cost of BU treatment consti-
tuted about 45% of the household annual income.
Intangible costs
About 92% of BU patients felt some form of pain during
the course of BU. Perceived pain and functional loss was
low among respondents. Children felt more pain (mean,
1.0 and 0.3 for children and adults respectively) but had
less functional loss compared to adults (mean, 0.8, 1.0 for
children and adults respectively) as shown in Figure 2.
The mean response of both adult and children BU cases
to stigma queries was 2.8. BU afflicted men were more
likely to indicate that others think less of them (p = 0.045).
There was no difference between male and female re-
sponses to other queries on stigma, perception of pain or
functional loss. About 84% of children were socially iso-
lated, with 36% of these children never being accompanied
for treatment. Those who were accompanied throughout
their treatment were 11%. The most cited reasons for this
phenomenon were that the children could go by them-
selves and lack of money for transportation.a, 2012
Economic cost (US$) Cost profile (%)
en (n = 45) Adults (n = 18) Total (n = 63)
(11.21)† 606.79 (33.71) 1,111.11 (17.64) 3.1
(1.19) 28.52 (1.58) 82.22 (1.31) 0.2
(12.40) 635.31 (35.30) 1,193.33 (18.94) 3.3
.67 (419.26) 9,150.33 (508.35) 28,017.00 (444.71) 78.1
63 (68.77) 1,300.00 (72.22) 4,394.63 (69.76) 12.2
(13.22) 337.66 (18.76) 932.35 (14.80) 2.6
.99 (501.24) 10,787.99 (599.33) 33,343.98 (529.27) 92.8
.01 (513.64) 11,423.30 (634.63) 34,537.31 (548.21) 96.2
* (7.40) 1,045.69 (58.09) 1,378.67 (21.88) 3.8








Figure 2 Mean responses of BU adults and children.
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The objective of this COIs study was to estimate house-
hold cost of BU in an endemic area. The distribution of
age, sex and location of BU lesions among respondents is
consistent with other BU studies [4,6,10,13]. The mean
cost of BU treatment of US$570.09 represents about 17%
of Ghana’s 2012 Gross Domestic Product (GDP) per capita
of $3,300a (PPP). The high direct cost reported is in keep-
ing with previous studies on healthcare costs [16,18]. High
contribution of non-medical direct costs mainly in the
form of transportation was also found in Hong Kong and
is explained by, the use of out-patient study participants
who required daily transportation to the health facility for
treatment [20]. We report lower food cost compared with
that of other chronic illness like tuberculosis and Human
Immunodeficiency Virus as BU patients do not typically
require a special diet [16]. A lower direct cost of BU in a
previous Ghanaian study is due to categorization of food
and miscellaneous costs as indirect cost as compared to
this study [6]. Low medical cost in our study stems from
the free and short duration of treatments (median,
3 months) offered [6]. Other drivers of direct costs like
co-morbidities and in-patient costs were not considered in
this study [28].
High indirect cost of BU has been documented in
Ghana and Cameroon among hospitalized patients
whose caregivers rented accommodation, or regularly
visited them [6,15]. We report lower indirect cost in this
study because- our respondents were resident at home,
most BU patients were students (75%) whose productivity
loss was not valued, most children were either never ac-
companied (36%), or accompanied less than 50% of the
times (48%) to the OHC for treatment- their caregivers
could therefore continue with their daily activities andhence incurred lower productivity losses (mean annual in-
direct cost, US$7.04). Very high indirect cost (about 80%
of total cost) documented among Swedish patients stems
from the sole use of study participants in the productive
age group in that study [21].
This study confirms that BU treatment poses significant
burden on households forming a 45% economic burden.
BU affected households are therefore likely to become
impoverished. Despite the high cost burden of BU, af-
fected households may be coping in the Ga South Munici-
pality due to financial assistance with transportation and
food costs from the NGO operating at the OHC. Commu-
nities that receive no such assistance are likely to develop
coping mechanisms like sale of assets, borrowing of
money and abandoning health facility based treatment
documented in other studies [15,17]. Sensitivity analysis
showed the estimated treatment costs were robust because
varying assumptions and uncertainty causes a minimal
2.1% change in total BU costs.
School days lost by children in this study (mean of
19 days) is lower than reported in Cameroon [15]. The
observed difference may be a consequence of choice of
study participants - hospitalized patients who could obvi-
ously not be in school in the Cameroonian study, versus
non-hospitalized patients who came for treatment and
went to school afterwards in our study. Hospitalizations of
BU patients suggest late presentation of BU requiring
lengthier treatment and as such loss of more school days
as compared with out-patient participants in this study.
This implies that child BU patients in this study reported
to the facility with early stages of BU. Such early reporting
can be explained by intensification of health education
and surveillance [29].
Buruli ulcer associated stigma is moderate among study
participants (mean, 2.8 for both adults and children). Me-
dian scores for stigma among BU sufferers were computed
using a four point Likert-like scale in an earlier study [24].
Acceptability of BU in this study community may be be-
cause stigma is reportedly low in highly endemic areas
and where the cause of BU is not ascribed to magico-
religious beliefs [14,24]. A preference to keep others from
knowing they have BU despite acceptability and sympathy
for BU patients, and lack of significant difference in male
and female response to stigmatizing behaviour we report,
is consistent with an earlier finding [14]. High levels of dis-
crimination of BU children among their peers reported
earlier in Ghana was observed to be absent in this study -
an attitude change attributable to increasing levels of
education about BU in schools in endemic areas [14,24].
Buruli ulcer is minimally painful when it presents as
an oedematous lesion and this explains a general report-
ing of mild degree of pain in this study [4]. Functional
limitation of BU patients in this study is described using
a 5 point Likert scale which contained 19 items of the
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was done using a 3 point Likert-like scale and computing
a functional loss that was a percentage of activities that a
BU sufferer could no longer perform (as a result of BU)
out of the 19 items of the BUFLSQ applicable to the BU
sufferer [22,23]. The low functional limitation documented
in this study is due to the selection of study participants
who generally had less extensive lesions and therefore
were seen on out-patient basis as compared to hospital-
ized patients who were likely to have more extensive
lesions requiring surgery in the previous studies [22].
Most children (84%) are socially isolated in this study.
Social isolation as a coping mechanism for high BU cost
of treatment was reported in Cameroon [15]. The higher
rate of social isolation among children in this study as
compared with the Cameroonian study (63% of house-
holds isolated their BU household member) can be ex-
plained by not just high BU treatment cost but also by
trust of caregivers in motorbike riders who are mostly
locals of the communities contracted by the OHC and
the operating NGO to transport all confirmed cases to
the OHC and back. The social isolation of the children
in this study may however, affect compliance with treat-
ment as caregivers are not present to ensure compliance.
This may in effect prolong treatment and further in-
crease treatment costs.Limitations of the study
The main limitation of this study is about the sample
which is facility-based rather than population based and
this can lead to selection bias. This data was however used
because they were confirmed cases well documented and
readily available. However, there is the likelihood of more
unreported cases in the communities. Although intangible
costs of BU like functional loss, social isolation, stigma
and pain were measured, they were not valued in monet-
ary terms as such an evaluation was beyond its scope.Conclusion
This study has shown that despite free BU health facility
based treatment; households incur substantial costs
seeking BU care. For non-hospitalized BU patients,
transportation cost can be enormous. Household cost of
BU is therefore essential in the design of BU interven-
tions. The total household cost of BU estimated in this
study can therefore serve as a baseline cost for strategic
planning and budgeting for future BU programmes,
informing policy makers in the setting up of a financial
framework on which future cost planning for BU will be
based. An economic evaluation of BU should be under-
taken with larger samples in other BU endemic areas to
provide a trend and variability in cost of this debilitating




BU: Buruli ulcer; BUFLSQ: Buruli Ulcer Functional Limitation Score
Questionnaire; CHPS: Community based Health Planning and Services;
COIs: Cost-of-Illness study; OHC: Obom Health Centre.
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